• KSAN
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Original Article

Factors related to Quality of Life of Patients with Ulcerative Colitis

Korean Journal of Adult Nursing 2014;26(2):129-138.
Published online: April 30, 2014

1College of Nursing, The Catholic University of Korea, Seoul

2Department of Nursing, Sun Moon University, Asan

3College of Nursing, Jeju National University, Jeju, Korea

Corresponding author: Cho, Ok-Hee College of Nursing, Jeju National University,102 Jejudaehak-ro, Jeju 690-756, Korea. Tel: +82-64-754-3887, Fax: +82-64-702-2686, E-mail: ohcho@jejunu.ac.kr
• Received: July 11, 2013   • Accepted: March 26, 2014

© 2014 Korean Society of Adult Nursing

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 19 Views
  • 0 Download
  • 1 Crossref
  • 1 Scopus
next
  • Purpose
    The purpose of this study was to identify factors related to the quality of life of patients with ulcerative colitis.
  • Methods
    A total 116 patients with ulcerative colitis were asked on general characteristics, illness-related characteristics, depression, and quality of life. The collected data were analyzed by t-test, ANOVA, and stepwise multiple regression.
  • Results
    As for depression the 81.03% were normal, the 8.62% were mild depression, the 6.90% were moderated depression, and the 3.45% were severe. As for quality of life, the social functions was highest, followed by intestine-related symptoms, systemic symptoms, and emotional functions. Quality of life was positively correlated to subjective health status, age, and body mass index, and negatively to depression. Main factors affecting the quality of life included depression, subjective health status, physician's global assessment, age, days of loss in social life, and present abdominal pain.
  • Conclusion
    Physical and psychosocial health problems related to ulcerative colitis affected the quality of life of the patients. Further research is warranted for developing educational programs and psychosocial strategies in order to efficiently handle the illness.
Table 1.
Differences in Quality of Life according to the General Characteristics of Subjects (N=116)
Characteristics Categories Total Quality of life
n (%) M±SD (range) M±SD t or F (p)
Age (year) <30 38 (32.8) 36.4±10.9 45.58±11.62a 9.48 (<.001)
30~39 33 (28.4) (18~68) 50.91±8.99b a<b
≥40 45 (38.8) 54.71±7.81b
Gender Male 55 (47.4) 51.04±9.76 0.40 (.692)
Female 61 (52.6) 50.28±10.67
Religion Yes 62 (53.4) 50.82±10.16 -0.21 (.836)
No 54 (46.6) 50.43±10.36
Education ≤High school 31 (26.7) 48.90±11.04 0.20 (.842)
≥College 85 (73.3) 51.27±9.88
Economic status Low 15 (12.9) 48.00±11.80 1.47 (.234)
Middle 86 (74.2) 50.47±10.18
High 15 (12.9) 54.27±8.11
Occupation Yes 73 (62.9) 51.22±9.30 -0.80 (.427)
No 43 (37.1) 49.65±11.64
Spouse Yes 70 (60.3) 53.49±7.24 3.93 (<.001)
No 46 (39.7) 46.30±12.42
BMI (kg/m2) <18.5 17 (14.7) 21.52±2.81 47.29±12.68a 5.08 (.008)
18.5~22.9 65 (56.0) (15.9~28.4) 49.20±10.01a a<b
≥23 34 (29.3) 55.06±7.80b
Subjective health status (VAS)     6.12±1.95    
(0~10)

BMI=body mass index; VAS=visual analogue scale; a, b=Duncan's multiple test.

Table 2.
Differences in Quality of Life according to the Disease-related Characteristics of Subjects (N=116)
Characteristics Categories Total Quality of life
n (%) M±SD t or F (p)
Age at onset (year) <30 63 (54.3) 48.83±11.30 2.22 (.004)
30~39 37 (31.9) 52.86±7.57
≥40 16 (13.8) 52.63±10.19
Disease duration (year) <3 29 (25.0) 49.41±9.64 0.33 (.723)
3~5 28 (24.1) 50.54±10.17
>5 59 (50.9) 51.29±10.60
Physician global assessment <2 95 (81.9) 52.29±9.67 3.95 (<.001)
≥2 21 (18.1) 43.14±9.36
Previous bowel surgery Yes 86 (74.1) 50.15±10.70 -0.87 (.387)
No 30 (25.9) 52.03±8.66
Previous admission Yes 81 (69.8) 50.35±11.25 0.55 (.584)
No 35 (30.2) 51.31±7.36
Melena/tarry stool (last week) Yes 48 (41.4) 47.19±9.97 -1.02 (.308)
No 68 (58.6) 53.07±9.73
Present abdomen pain Yes 58 (50.0) 46.60±9.95 4.62 (<.001)
No 58 (50.0) 54.67±8.84
Days of loss in social life (for the recent one year) <7 90 (77.6) 52.39±9.21 3.61 (<.001)
≥7 26 (22.4) 44.58±11.32
Medication Steroids
Steroids Yes 48 (41.4) 50.27±10.15 0.32 (.747)
No 68 (58.6) 50.90±10.32
Immunosuppresives Yes 47 (40.5) 52.11±9.27 -1.28 (.202)
No 69 (59.5) 49.64±10.75
5-aminosalicylic acid Yes 35 (30.2) 53.86±8.08 -2.27 (.025)
No 81 (69.8) 49.25±10.75

Subjects may select more than one item.

Table 3.
Quality of Life and Depression of the Subjects (N=116)
Characteristics Categories n (%) or M±SD Range
Quality of life Total 5.06±1.02 1~7
Emotion 4.77±1.35 1~7
Symptom 4.91±1.09 1~7
Behavior 5.21±1.03 1~7
Social factors 5.50±1.50 1~7
Depression   9.03±7.83  
Normal 94 (81.03) 0~13
Mild depression 10 (8.62) 14~19
Moderate depression 8 (6.90) 20~28
Severe depression 4 (3.45) 29~63
Table 4.
Correlations between the Quality of Life and the Related Variables (N=116)
Variables Quality of life
r p
Depression -.61 <.001
Subjective health status .59 <.001
Age (year) .34 <.001
BMI (kg/m2) .25 .008

BMI=body mass index.

Table 5.
Factors Influencing Participants' Quality of Life (N=116)
Predictors Standardized β t (p)
Depression -.44 -6.70
(<.001)
Subjective health status .26 3.81
(<.001)
PGA -.22 -3.44
(reference: <2 scores)   (<.001)
Age .19 3.15
(.002)
Days of loss in social life -.11 -1.79
(reference: <7 days/yr)   (.077)
Present abdomen pain -.12 -1.82
(reference: no)   (.073)
Adjusted R2=.63, F=33.37,
p<.001

PGA=physician's global assessment.

  • Ananthakrishnan A. N., McGinley E. L., Binion D. G.. 2009;Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations. Inflammatory Bowel Disease. 15(2):182–-189. http://dx.doi.org/10.1002/ibd.20628.
  • Beck A. T., Steer R. A., Brown G. K.. 1996. BDI-II, Beck depression inentory: Mannual. 2nd ed. San Antonia, TX: Psychological Corporation.
  • Boye B., Jahnsen J., Mokleby K., Leganger S., Jantschek G., Jantschek I., et al. 2008;The INSPIRE study: Are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease? Inflammatory Bowel Disease. 14(5):680–-686. http://dx.doi.org/10.1002/ibd.20367.
  • Casellas F., Arenas J. I., Baudet J. S., Fábregas S., García N., Gelabert J., et al. 2005;Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish multicenter study. Inflammatory Bowel Disease. 11(5):488–-496.
  • Cho O. H., Yoo Y. S., Yang S. K.. 2012;Depression and risk factors in patients with Crohn's disease. Journal of Korean Academy of Nursing. 42(2):207–-216. http://dx.doi.org/10.4040/jkan.2012.42.2.207.
  • Choi C. H., Jung S. A., Lee B. I., Lee K. M., Kim J. S., Han D. S.. 2009;Diagnostic guideline of ulcerative colitis. The Korean Journal of Gastroenterology. 53(3):145–-160.
  • Chung G. E., Cheon J. H., Lee J. Y., Ye B. D., Kim S. G., Kim J. S.. 2006;Efficacy of combination of intravenous cyclosporin A and steroid therapy versus prolonged intravenous steroid therapy alone in patients with severe ulcerative colitis refractory to initial intravenous steroid therapy. The Korean Journal of Gastroenterology. 48(4):263–-268.
  • D'Haens G., Sandborn W. J., Feagan B. G., Geboes K., Hana-uer S. B., Irvine E. J., et al. 2007;A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 132(2):763–-786.
  • Faul F., Erdfelder E., Buchner A., Lang A. G.. 2009;Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 41:1149–-1160. http://dx.doi.org/10.3758/BRM.41.4.1149.
  • Fuller-Thomson E., Sulman J.. 2006;Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflammatory Bowel Disease. 12(8):697–-707. http://dx.doi.org/10.1097/00054725-200608000-00005.
  • Graff L. A., Walker J. R., Bernstein C. N.. 2009;Depression and anxiety in inflammatory bowel disease: A review of cormobidity and management. Inflammatory Bowel Disease. 15(7):1105–-1118. http://dx.doi.org/10.1002/ibd.20873.
  • Haapamäki J., Roine R. P., Turunen U., Färkkilä M. A., Ark-kila P. E.. 2011;Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. Journal of Crohn's and Colitis. 5(1):41–-47. http://dx.doi.org/10.1016/j.crohns.2010.09.008.
  • Han S. W., McColl E., Barton J. R., James P., Steen I. N., Welfare M. R.. 2005;Predictors of quality of life in ulcerative colitis: The importance of symptoms and illness representations. Inflammatory Bowel Disease. 11:24–-34.
  • Hoivik M. L., Moum B., Solberg I. C., Cvancarova M., Hoie O., Vatn M. H., et al. 2012;Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: Results from the IBSEN study. Inflammatory Bowel Disease. 18(8):1540–-1549. http://dx.doi.org/10.1002/ibd.21863.
  • Irvine E. J.. 2008;Quality of life of patients with ulcerative colitis: Past, present and future. Inflammatory Bowel Disease. 14(4):554–-565.
  • Irvine E. J., Zhou Q., Thompson A. K.. 1996;The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. The American Journal of Gastroenterology. 91:1571–-1578.
  • Kim M. S., Lee I. S., Lee C. S.. 2007;The validation studyⅠ of Korean BDI-Ⅱ: In female university students sample. The Korean Journal of Clinical Psychology. 26:997–-1014.
  • Korean Association for the Study of the Intestinal Diseases. 2003. Crohn's Disease. Seoul: Jin.
  • Kornbluth A., Sachar D. B.. 2004;Ulcerative colitis practice guidelines in adults (update): American college of gastroenterology, practice parameters committee. The American Journal of Gastroenterology. 99(7):1371–-1385.
  • Langhorst J., Mueller T., Luedtke R., Franken U., Paul A., Mi-chalsen A., et al. 2007;Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: A twelve-month follow-up. Scandinavian Journal of Gastroenterology. 42(6):734–-745.
  • Lee J. H., Cheon J. H., Moon C. M., Park J. J., Hong S. P., Kim T. I., et al. 2010;Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Digestion. 81(4):237–-243. http://dx.doi.org/10.1159/000253850.
  • Lix L. M., Graff L. A., Walker J. R., Clara I., Rawsthorne P., Rogala L., et al. 2008;Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Disease. 14(11):1575–-1584. http://dx.doi.org/10.1002/ibd.20511.
  • Mawdsley J. E., Rampton D. S.. 2005;Psychological stress in IBD: New insights into pathogenic and therapeutic implication. Gut. 54(10):1481–-1491.
  • Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., et al. 2004;Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosomatic Medicine. 66(1):79–-84. http://dx.doi.org/10.1097/01.PSY.0000106907.24881.F2.
  • Moscandrew M., Mahadevan U., Kane S.. 2009;General health maintenance in IBD. Inflammatory Bowel Diseases. 15(9):1399–-1409. http://dx.doi.org/10.1002/ibd.20944.
  • Shin I. S.. 2005;The factors that influence the quality of life in cancer patients Unpublished master's thesis, Kyung Hee University. Seoul..
  • Tanaka M., Kazuma K.. 2005;Ulcerative colitis: Factors affecting difficulties of life and psychological well being of patients in remission. Journal of Clinical Nursing. 14(1):65–-73.
  • Van der Eijk I., Vlachonikolis I. G., Munkholm P., Nijman J., Bernklev T., Politi P., et al. 2004;The role of quality of care in health-related quality of life in patients with IBD. Inflammatory Bowel Disease. 10(4):392–-398.
  • WHO/IASO/IOTF. 2000;The Asia-Pacific Perspective: Redefining Obesity and its Treatment Health Communications Australia Pty Ltd. Retrieved February 10, 2014, from.http://www.wpro.who.int/nutrition/documents/Redefining_obesity/en.
  • Yang D. H., Yang S. K.. 2009;Trends in the incidence of ulcerative colitis in Korea. Korean Journal of Medicine. 76(6):637–-642.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Factors affecting the health status of patients with type 2 diabetes mellitus receiving insulin treatments: A multi‐mediation path analysis
      Kang Sun Lee, Hye Young Kim, Heung Young Jin
      Journal of Clinical Nursing.2022; 31(9-10): 1285.     CrossRef

    Download Citation

    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:

    Include:

    Factors related to Quality of Life of Patients with Ulcerative Colitis
    Korean J Adult Nurs. 2014;26(2):129-138.   Published online April 30, 2014
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Factors related to Quality of Life of Patients with Ulcerative Colitis
    Korean J Adult Nurs. 2014;26(2):129-138.   Published online April 30, 2014
    Close
    Factors related to Quality of Life of Patients with Ulcerative Colitis
    Factors related to Quality of Life of Patients with Ulcerative Colitis

    Differences in Quality of Life according to the General Characteristics of Subjects (N=116)

    Characteristics Categories Total Quality of life
    n (%) M±SD (range) M±SD t or F (p)
    Age (year) <30 38 (32.8) 36.4±10.9 45.58±11.62a 9.48 (<.001)
    30~39 33 (28.4) (18~68) 50.91±8.99b a<b
    ≥40 45 (38.8) 54.71±7.81b
    Gender Male 55 (47.4) 51.04±9.76 0.40 (.692)
    Female 61 (52.6) 50.28±10.67
    Religion Yes 62 (53.4) 50.82±10.16 -0.21 (.836)
    No 54 (46.6) 50.43±10.36
    Education ≤High school 31 (26.7) 48.90±11.04 0.20 (.842)
    ≥College 85 (73.3) 51.27±9.88
    Economic status Low 15 (12.9) 48.00±11.80 1.47 (.234)
    Middle 86 (74.2) 50.47±10.18
    High 15 (12.9) 54.27±8.11
    Occupation Yes 73 (62.9) 51.22±9.30 -0.80 (.427)
    No 43 (37.1) 49.65±11.64
    Spouse Yes 70 (60.3) 53.49±7.24 3.93 (<.001)
    No 46 (39.7) 46.30±12.42
    BMI (kg/m2) <18.5 17 (14.7) 21.52±2.81 47.29±12.68a 5.08 (.008)
    18.5~22.9 65 (56.0) (15.9~28.4) 49.20±10.01a a<b
    ≥23 34 (29.3) 55.06±7.80b
    Subjective health status (VAS)     6.12±1.95    
    (0~10)

    BMI=body mass index; VAS=visual analogue scale; a, b=Duncan's multiple test.

    Differences in Quality of Life according to the Disease-related Characteristics of Subjects (N=116)

    Characteristics Categories Total Quality of life
    n (%) M±SD t or F (p)
    Age at onset (year) <30 63 (54.3) 48.83±11.30 2.22 (.004)
    30~39 37 (31.9) 52.86±7.57
    ≥40 16 (13.8) 52.63±10.19
    Disease duration (year) <3 29 (25.0) 49.41±9.64 0.33 (.723)
    3~5 28 (24.1) 50.54±10.17
    >5 59 (50.9) 51.29±10.60
    Physician global assessment <2 95 (81.9) 52.29±9.67 3.95 (<.001)
    ≥2 21 (18.1) 43.14±9.36
    Previous bowel surgery Yes 86 (74.1) 50.15±10.70 -0.87 (.387)
    No 30 (25.9) 52.03±8.66
    Previous admission Yes 81 (69.8) 50.35±11.25 0.55 (.584)
    No 35 (30.2) 51.31±7.36
    Melena/tarry stool (last week) Yes 48 (41.4) 47.19±9.97 -1.02 (.308)
    No 68 (58.6) 53.07±9.73
    Present abdomen pain Yes 58 (50.0) 46.60±9.95 4.62 (<.001)
    No 58 (50.0) 54.67±8.84
    Days of loss in social life (for the recent one year) <7 90 (77.6) 52.39±9.21 3.61 (<.001)
    ≥7 26 (22.4) 44.58±11.32
    Medication Steroids
    Steroids Yes 48 (41.4) 50.27±10.15 0.32 (.747)
    No 68 (58.6) 50.90±10.32
    Immunosuppresives Yes 47 (40.5) 52.11±9.27 -1.28 (.202)
    No 69 (59.5) 49.64±10.75
    5-aminosalicylic acid Yes 35 (30.2) 53.86±8.08 -2.27 (.025)
    No 81 (69.8) 49.25±10.75

    Subjects may select more than one item.

    Quality of Life and Depression of the Subjects (N=116)

    Characteristics Categories n (%) or M±SD Range
    Quality of life Total 5.06±1.02 1~7
    Emotion 4.77±1.35 1~7
    Symptom 4.91±1.09 1~7
    Behavior 5.21±1.03 1~7
    Social factors 5.50±1.50 1~7
    Depression   9.03±7.83  
    Normal 94 (81.03) 0~13
    Mild depression 10 (8.62) 14~19
    Moderate depression 8 (6.90) 20~28
    Severe depression 4 (3.45) 29~63

    Correlations between the Quality of Life and the Related Variables (N=116)

    Variables Quality of life
    r p
    Depression -.61 <.001
    Subjective health status .59 <.001
    Age (year) .34 <.001
    BMI (kg/m2) .25 .008

    BMI=body mass index.

    Factors Influencing Participants' Quality of Life (N=116)

    Predictors Standardized β t (p)
    Depression -.44 -6.70
    (<.001)
    Subjective health status .26 3.81
    (<.001)
    PGA -.22 -3.44
    (reference: <2 scores)   (<.001)
    Age .19 3.15
    (.002)
    Days of loss in social life -.11 -1.79
    (reference: <7 days/yr)   (.077)
    Present abdomen pain -.12 -1.82
    (reference: no)   (.073)
    Adjusted R2=.63, F=33.37,
    p<.001

    PGA=physician's global assessment.

    Table 1. Differences in Quality of Life according to the General Characteristics of Subjects (N=116)

    BMI=body mass index; VAS=visual analogue scale; a, b=Duncan's multiple test.

    Table 2. Differences in Quality of Life according to the Disease-related Characteristics of Subjects (N=116)

    Subjects may select more than one item.

    Table 3. Quality of Life and Depression of the Subjects (N=116)

    Table 4. Correlations between the Quality of Life and the Related Variables (N=116)

    BMI=body mass index.

    Table 5. Factors Influencing Participants' Quality of Life (N=116)

    PGA=physician's global assessment.

    TOP